ABEV, US02319V1035

Ambev stock draws an Underperform call with a USD 3.30 target

Published on 10/08/2026 at 01:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambev stock enters the next report with Q2 normalized EBITDA up 8.9 percent to BRL 6.4 billion. The next results date is October 29, 2026.

ABEV, US02319V1035, Illustration mit AI erstellt.
ABEV, US02319V1035, Illustration mit AI erstellt.

Ambev stock (ISIN US02319V1035) carried a market capitalization of USD 48.7 billion on the NYSE on October 7, 2026. The immediate signal came from MarketBeat on October 7, 2026, which reported that Bank of America reaffirmed an Underperform rating and set a USD 3.30 price target.

Bank of America keeps a cautious stance

The USD 3.30 target lies 4.8 percent above the USD 3.15 price used for the comparison. Bank of America remains more cautious than the broader published view, making the rating action the clearest near-term counterweight to Ambev's operating progress.

MarketBeat also reported an average Reduce rating, with four analysts at Hold and two at Sell, and a consensus target of USD 3.13. That target is below the USD 3.15 reference price, so the consensus is less constructive than the Bank of America target.

Q2 profit growth outpaced revenue

In Q2 FY2026, normalized EBITDA rose 8.9 percent to BRL 6.4 billion, while normalized EPS increased 24.2 percent to BRL 0.22, according to ScanX News in its September 18, 2026 report. The comparison matters because earnings growth substantially exceeded the 6 percent increase in net revenue.

The same Q2 report put operating cash flow for the first half of 2026 at BRL 7.9 billion, up more than 80 percent year over year. Beer volume growth and premium products supported the result, while weaker nonalcoholic beverage volumes remained a pressure point in the operating mix.

Stock stays below the yearly high

Ambev stock was last at USD 3.15 on the NYSE on October 7, 2026 at 4:00 p.m. ET, down 2.17 percent from USD 3.22. The session range was USD 3.13 to USD 3.19, while the 52-week range stood at USD 2.10 to USD 3.45 and volume reached 28,375,205 shares.

Key facts on Ambev stock

  • Company: Ambev S.A.
  • ISIN: US02319V1035
  • Ticker: ABEV
  • Trading venue: NYSE
  • Price (as of October 7, 2026, 4:00 p.m. ET): USD 3.15
  • Market capitalization: USD 48.7 billion (as of October 7, 2026)
  • 52-week range: USD 2.10-3.45 (as of October 7, 2026)
  • Sector / Industry: Consumer Defensive / Beverages - Brewers

Upcoming dates for Ambev stock

  • October 29, 2026: Q3 FY2026 results before the opening of the B3 and NYSE

Ambev scheduled the Q3 FY2026 results release for October 29, 2026, with the webcast set for 11:30 a.m. New York time. The company also listed the results date on its investor-relations page.

More news and analysis on Ambev stock

Disclaimer...

en | US02319V1035 | ABEV | boerse | 70260040 | bgmi